Posted Oct. 29, 2012 at 5:16 a.m.
HIV research
Image 1 of 2 · Next Image…
Research Triangle Park, N.C. — Japanese drugmaker Shionogi & Co. entered a joint venture between GlaxoSmithKline and Pfizer as the three companies prepare to seek regulatory approval for their experimental HIV medicine....
Japanese drug firm takes 10% stake in GSK-Pfizer joint venture
Post a comment
Print this blog postE-mail blog post
Share
HIV research
Image 1 of 2 · Next Image…
Research Triangle Park, N.C. — Japanese drugmaker Shionogi & Co. entered a joint venture between GlaxoSmithKline and Pfizer as the three companies prepare to seek regulatory approval for their experimental HIV medicine....
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 WRAL Tech Wire and the Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.Please log in to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
NC Biotech Center braces for worst as Senate slashes budget, too- ArchiveSocial, a new Durham success story, brings home international award
- Durham's high-tech infrastructure, talent lure Virginia company
- Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
- Raleigh-based PRA International eyes public offering
- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows